PubRank

Nobuyuki Ura

Author PubWeight™ 46.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009 2.66
2 Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 2007 2.58
3 Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007 2.20
4 Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity. J Hypertens 2004 1.81
5 Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 2008 1.70
6 Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: a possible beneficial effect of renin-angiotensin system inhibition on left atrial function. Hypertens Res 2007 1.64
7 Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003 1.62
8 Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme. Hypertens Res 2006 1.57
9 Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial. J Hypertens 2014 1.56
10 Serum ratio of heart-type fatty acid-binding protein to myoglobin. A novel marker of cardiac damage and volume overload in hemodialysis patients. Nephron Clin Pract 2003 1.53
11 Olmesartan ameliorates insulin sensitivity by modulating tumor necrosis factor-alpha and cyclic AMP in skeletal muscle. Hypertens Res 2005 1.43
12 Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls and patients with atrial fibrillation. J Am Soc Echocardiogr 2005 1.35
13 Insulin sensitivity and lipid metabolism in human CD36 deficiency. Diabetes Care 2003 0.99
14 Liddle's syndrome caused by a novel mutation in the proline-rich PY motif of the epithelial sodium channel beta-subunit. J Clin Endocrinol Metab 2004 0.98
15 Assessment of left ventricular ejection fraction using long-axis systolic function is independent of image quality: a study of tissue Doppler imaging and m-mode echocardiography. Echocardiography 2006 0.98
16 Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension. Circ J 2004 0.97
17 Visceral obesity in Japanese patients with metabolic syndrome: reappraisal of diagnostic criteria by CT scan. Hypertens Res 2007 0.94
18 Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients. Heart Vessels 2008 0.91
19 Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation. Int Immunopharmacol 2002 0.87
20 Circulating resistin levels in essential hypertension. Clin Endocrinol (Oxf) 2003 0.86
21 Effect of TNF-alpha--converting enzyme inhibitor on insulin resistance in fructose-fed rats. Hypertension 2002 0.86
22 Chinese medicine, Jiang-Tang-Ke-Li, improves insulin resistance by modulating muscle fiber composition and muscle tumor necrosis factor-alpha in fructose-fed rats. Hypertens Res 2003 0.85
23 Mechanisms of insulin resistance in hypertensive rats. Clin Exp Hypertens 2006 0.85
24 Role of adiponectin in insulin-resistant hypertension and atherosclerosis. Hypertens Res 2003 0.83
25 Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis. Nephrol Dial Transplant 2002 0.83
26 Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol (Oxf) 2004 0.82
27 Tissue-specific impairment of insulin signaling in vasculature and skeletal muscle of fructose-fed rats. Hypertens Res 2003 0.82
28 The effect of tumor necrosis factor-alpha on tissue specificity and selectivity to insulin signaling. Hypertens Res 2003 0.82
29 Low adiponectin level in young normotensive men with a family history of essential hypertension. Hypertens Res 2005 0.82
30 Early defibrillation and circulatory support can provide better long-term outcomes through favorable neurological recovery in patients with out-of-hospital cardiac arrest of cardiac origin. Circ J 2005 0.81
31 The role of bradykinin B1 receptor on cardiac remodeling in stroke-prone spontaneously hypertensive rats (SHR-SP). Biol Chem 2006 0.81
32 Possible impairment of transcardiac utilization of adiponectin in patients with type 2 diabetes. Diabetes Care 2004 0.80
33 Persistent insulin-sensitizing effects of sarpogrelate hydrochloride, a serotonin 2A receptor antagonist, in patients with peripheral arterial disease. Circ J 2006 0.80
34 Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats. Clin Exp Pharmacol Physiol 2004 0.80
35 Renal protective role of bradykinin B1 receptor in stroke-prone spontaneously hypertensive rats. Hypertens Res 2004 0.79
36 Utility of serum ratio of heart-type fatty acid-binding protein to myoglobin for cardiac damage regardless of renal dysfunction. Circ J 2004 0.79
37 Angiotensin II inhibits glucose uptake of skeletal muscle via the adenosine monophosphate-activated protein kinase pathway. J Am Soc Hypertens 2010 0.78
38 Bradykinin release and inactivation in brain of rats submitted to an experimental model of Alzheimer's disease. Peptides 2006 0.78
39 [Case report; mycotic aneurysm caused by Listeria monocytogenes]. Nihon Naika Gakkai Zasshi 2011 0.78
40 Effects of angiotensin II receptor blockade on glucose metabolism via AMP-activated protein kinase in insulin-resistant hypertensive rats. J Am Soc Hypertens 2008 0.77
41 [Adiponectin levels and coronary risk factors in the elderly]. Nihon Ronen Igakkai Zasshi 2004 0.76
42 Effects of angiotensin II type 1 receptor gene polymorphisms on insulin resistance in a Japanese general population: the Tanno-Sobetsu study. Hypertens Res 2006 0.76
43 [Molecular biology in regulation of kidney functions: Kallikrein-kinin system (bradykinin)]. Nihon Rinsho 2006 0.75
44 Long-term outcome of implanted cardioverter defibrillators in survivors of out-of-hospital cardiac arrest of cardiac origin. Circ J 2006 0.75
45 [Metabolic syndrome and insulin resistance]. Nihon Naika Gakkai Zasshi 2006 0.75
46 The role of renal natriuretic and depressor systems in insulin-resistant hypertensive rats. Hypertens Res 2004 0.75
47 [TNF-alpha]. Nihon Rinsho 2006 0.75
48 [Discussion meeting on optimization of antihypertensive treatment in the JSH2009 era]. Nihon Naika Gakkai Zasshi 2011 0.75
49 [Contribution of diuretics to the treatment of hypertension in patients with CKD]. Nihon Jinzo Gakkai Shi 2009 0.75
50 [Chronic kidney diseases and various other diseases: 8. Metabolic syndrome]. Nihon Naika Gakkai Zasshi 2007 0.75
51 [Case report: two cases of proteinase-3-antineutrophil cytoplasmic antibody (PR3-ANCA) positive infection related glomerulonephritis]. Nihon Naika Gakkai Zasshi 2012 0.75
52 [Role of kallikrein-kinin system in blood pressure regulation]. Nihon Rinsho 2006 0.75
53 Effects of neutral endopeptidase 24.11 inhibition on myocardial infarct size and ischemic preconditioning in rabbits. Naunyn Schmiedebergs Arch Pharmacol 2002 0.75
54 [Effects of Ca channel blockers on glucose metabolism and insulin sensitivity]. Nihon Rinsho 2005 0.75